 | Up a level |
Franzone, Anna; Zaugg, Serge; Piccolo, Raffaele; Modena, Maria Grazia; Mikhail, Ghada W; Ferré, Josepa Mauri; Strasser, Ruth; Grinfeld, Liliana; Heg, Dik; Jüni, Peter; Windecker, Stephan; Morice, Marie-Claude (2017). A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study. PLoS ONE, 12(8), e0182632. Public Library of Science 10.1371/journal.pone.0182632
Lauten, Alexander; Engström, Annemarie E; Jung, Christian; Empen, Klaus; Erne, Paul; Cook, Stéphane; Windecker, Stephan; Bergman, Manfred Max; Klingenberg, Roland; Lüscher, Thomas F; Haude, Michael; Rulands, Dierk; Butter, Christian; Ullman, Bengt; Hellgren, Laila; Modena, Maria Grazia; Pedrazzini, Giovanni; Henriques, Jose P S; Figulla, Hans R and Ferrari, Markus (2013). Response to letter regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK registry”. Circulation - heart failure, 6(4), e56. Lippincott Williams & Wilkins
Lauten, Alexander; Engström, Annemarie E.; Jung, Christian; Empen, Klaus; Erne, Paul; Cook, Stéphane; Windecker, Stephan; Bergman, Manfred Max; Klingenberg, Roland; Lüscher, Thomas F.; Haude, Michael; Rulands, Dierk; Butter, Christian; Ullman, Bengt; Hellgren, Laila; Modena, Maria Grazia; Pedrazzini, Giovanni; Henriques, Jose P. S.; Figulla, Hans R. and Ferrari, Markus (2013). Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circulation - heart failure, 6(1), pp. 23-30. Lippincott Williams & Wilkins 10.1161/CIRCHEARTFAILURE.112.967224
Morice, Marie-Claude; Mikhail, Ghada W; Mauri i Ferré, Fina; Modena, Maria Grazia; Strasser, Ruth H; Grinfeld, Liliana; Sudhir, Krishnankutty; Stuteville, Marrianne; Papeleu, Peggy; Li, Dong; Rutledge, David; Windecker, Stephan (2012). SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes. EuroIntervention, 8(3), pp. 325-35. Toulouse: Europa Digital & Publishing
